600196.SS or CIPLA.NS: which is the higher-quality business?
Same dated snapshot (2026-09-01): 600196.SS scores —/100 vs CIPLA.NS —/100 on the rule-based Berkshire checklist (unscored vs unscored band). Quality grades the business only — the lower-quality name can still be the better deal at the right price.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 600196.SS (Fosun Pharma) | CIPLA.NS (Cipla) | |
| Market / sector | ashare · Pharma | in · Pharma |
| Price | ¥22.84 | ₹1,407 |
| Quality score | —/100 | —/100 |
| Engine signal | LONG · 38 bars · uPnL -3.6% | LONG · 90 bars · uPnL +7.7% |
| Total return | -1.8% | +3.1% |
Cite this page
Balance Labs Research Desk (2026-09-01). "600196.SS or CIPLA.NS: which is the higher-quality business?." balancelabs.app · https://balancelabs.app/stocks/compare/600196.ss-vs-cipla.ns/q/600196.ss-or-cipla.ns-higher-quality · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← 600196.SS vs CIPLA.NS · snapshot 2026-09-01 · not investment advice